
Deciphera Pharmaceuticals DCPH
Annual report 2023
added 02-07-2024
Deciphera Pharmaceuticals Total Inventories 2011-2026 | DCPH
Annual Total Inventories Deciphera Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.2 M | 20.6 M | 14.1 M | 5.72 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.2 M | 5.72 M | 15.4 M |
Quarterly Total Inventories Deciphera Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.1 M | 25.3 M | 25.5 M | 20.6 M | 19.1 M | - | 19.6 M | 14.1 M | 7.25 M | 8.21 M | 7.09 M | 5.72 M | 5.72 M | 5.72 M | 5.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27.1 M | 5.72 M | 14.1 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
6.34 M | $ 3.55 | -0.28 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.79 | 0.05 % | $ 4.31 M | ||
|
BioCardia
BCDA
|
4 K | $ 1.3 | 1.97 % | $ 27.5 M | ||
|
Catalyst Biosciences
CBIO
|
4.28 M | $ 11.3 | -2.46 % | $ 1.01 B | ||
|
Anika Therapeutics
ANIK
|
46.4 M | $ 14.59 | 1.6 % | $ 214 M | ||
|
AVEO Pharmaceuticals
AVEO
|
1.66 M | - | - | $ 521 M | ||
|
Aytu BioScience
AYTU
|
11.4 M | $ 2.63 | -0.57 % | $ 16.5 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.52 | 0.33 % | $ 388 M |